NCT05337592View on ClinicalTrials.gov

A Study in Healthy Men to Test How Different Doses of BI 1815368 Are Tolerated and How BI 1815368 is Taken up in the Body With or Without Food

PHASE1CompletedINTERVENTIONAL
Enrollment

72

Participants

Timeline

Start Date

June 14, 2022

Primary Completion Date

October 18, 2022

Study Completion Date

October 18, 2022

Conditions
Healthy
Interventions
DRUG

BI 1815368 formulation 1

BI 1815368 formulation 1

DRUG

Placebo

Placebo

DRUG

BI 1815368 formulation 2

BI 1815368 formulation 2

Trial Locations (1)

88397

Humanpharmakologisches Zentrum Biberach, Biberach

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY

NCT05337592 - A Study in Healthy Men to Test How Different Doses of BI 1815368 Are Tolerated and How BI 1815368 is Taken up in the Body With or Without Food | Biotech Hunter | Biotech Hunter